Streetbeat News

Stock Prices

CUZ

Analysts have varied opinions on Cousins Properties (NYSE:CUZ), with recent ratings showing a mix of bullish and indifferent sentiments. The average 12-month price target has increased to $30.17, indicating positive expectations. The company's financials show strong revenue growth and net margin, but challenges in ROE.

Portfolio Pulse from Benzinga Insights

September 16, 2024 | 7:01 pm

MRK

Analysts have mixed views on Merck & Co (NYSE:MRK) with recent evaluations showing a mix of bullish and bearish perspectives. The average 12-month price target has decreased by 2.29% to $144.12. Merck's financials show strong profitability and effective cost management, with a net margin of 33.86% and a ROE of 13.0%.

Portfolio Pulse from Benzinga Insights

September 16, 2024 | 7:00 pm

RNA

Avidity Biosciences (NASDAQ:RNA) has received mixed analyst ratings over the past three months, with a majority being somewhat bullish. The average 12-month price target has increased to $68.86. Despite challenges like a decline in revenue and low net margins, the company shows strong ROE and low debt dependency.

Portfolio Pulse from Benzinga Insights

September 16, 2024 | 7:00 pm

RXRX

Recursion Pharmaceuticals (NYSE:RXRX) has seen a significant rise in short interest, with 27.68% of its float sold short, compared to a peer average of 13.52%. This indicates increased bearish sentiment, although it doesn't guarantee a price drop.

Portfolio Pulse from Benzinga Insights

September 16, 2024 | 7:00 pm

NUE

Nucor's short interest has increased by 5.19%, with 4.46 million shares sold short, representing 2.43% of its float. This is below the peer group average of 5.08%. The rise in short interest may indicate bearish sentiment, but it doesn't guarantee a price drop.

Portfolio Pulse from Benzinga Insights

September 16, 2024 | 7:00 pm

ALLR

Allarity Therapeutics (NYSE:ALLR) has seen a significant increase in short interest, with 40.86% of its float sold short, a 5654.93% rise since the last report. This high short interest compared to its peers could indicate bearish sentiment, but it may also present a bullish opportunity if the stock price rises.

Portfolio Pulse from Benzinga Insights

September 16, 2024 | 7:00 pm

HAS

In the past three months, five analysts have provided ratings on Hasbro (NASDAQ:HAS), with a mix of bullish and somewhat bullish sentiments. The average 12-month price target has increased by 2.4% to $76.8. Analysts have raised their price targets, reflecting a positive outlook despite Hasbro's recent revenue decline.

Portfolio Pulse from Benzinga Insights

September 16, 2024 | 7:00 pm

IEP

Icahn Enterprises shares rose after a district court judge dismissed a class action lawsuit against the company, its directors, and officers without prejudice.

Portfolio Pulse from Benzinga Newsdesk

September 16, 2024 | 6:59 pm

VEEE

Twin Vee PowerCats shares rose following the announcement of a new automotive-inspired buy/sell marketplace and a digital end-to-end boat buying platform.

Portfolio Pulse from Benzinga Newsdesk

September 16, 2024 | 6:56 pm